Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels

被引:29
|
作者
Borg, Cynthia M.
Le Roux, Carel W.
Ghatei, Mohammad A.
Bloom, Stephen R.
Patel, Ameet G.
机构
[1] Kings Coll Hosp London, Dept Gen Surg, London SE5 9RS, England
[2] Hammersmith Hosp, Imperial Coll, Dept Met Med, London, England
基金
英国生物技术与生命科学研究理事会;
关键词
biliopancreatic diversion; animal model; gut hormones; intestinal hypertrophy;
D O I
10.1007/BF02802090
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Factors leading to weight loss and weight stabilization after bariatric surgery are not fully understood. The aims of this study were to develop an animal model for bilicipancreatic diversion (BPD) and to determine changes in gut hormones, malabsorption and small bowel histology postoperatively. Methods: 2 groups of Wistar rats underwent sham and BPD surgery. Daily postoperative weights and food intake were measured. 24-hour fecal collections were performed at Day 6 and 21. Bomb calorimetry was performed to determine the fecal calorific values. At day 23, levels of peptide YY (PYY), glucagon-like peptide 1 (GLP-1) and glucagon-like peptide 2 (GLP-2) were determined and small bowel biopsies were taken. Results: Animals in the BPD group had significant reduction in weight (P < 0.001) and in food intake (P<0.001) compared to the sham group. Serum levels of PYY, GLP-1 and GLP-2 in the BPD group were significantly higher (P < 0.005). Animals in the BPD group had significantly higher fecal energy content at Day 6 (P < 0.001) but not at Day 21 when compared to the sham group. Small bowel histology confirmed the presence of significantly increased mitosis (P=0.03) and labelled cells (P=0.002) in the BPD animals when compared to sham. Conclusions: In our animal model, the higher levels of PYY, GLP-1 and GLP-2 after BPD may be due to gut adaptation and hypertrophy and could be important in inducing and maintaining weight loss after bariatric surgery.
引用
收藏
页码:1193 / 1198
页数:6
相关论文
共 50 条
  • [1] Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels
    Borg C.M.
    Roux C.W.L.
    Ghatei M.A.
    Bloom S.R.
    Patel A.G.
    Obesity Surgery, 2007, 17 (9) : 1193 - 1198
  • [2] Glucose Metabolism Improvements Following Biliopancreatic Diversion in Rat are Associated With GLP-1 and PYY
    Baraboi, Elena-Dana
    Li, Wei
    Labbe, SeBastien
    Roy, Marie-Claude
    Bouchard, Cynthia
    Samson, Pierre
    Moustarah, Fady
    Biertho, Laurent
    Richard, Denis
    DIABETES, 2013, 62 : A728 - A728
  • [3] Intestinal proliferation and reduced intestinal transit time in a patient diagnosed with a GLP-1, GLP-2 and PYY producing neuroendocrine carcinoma
    Byrne, MM
    McGregor, GP
    Goke, B
    Arnold, R
    GASTROENTEROLOGY, 1999, 116 (04) : A595 - A595
  • [4] Postprandial GLP-2 Levels Are Increased After Biliopancreatic Diversion in Diabetic Individuals with Class I Obesity: a Prospective Study
    Everton Cazzo
    José Carlos Pareja
    Bruno Geloneze
    Elinton Adami Chaim
    Maria Rita Lazzarini Barreto
    Daniéla Oliveira Magro
    Obesity Surgery, 2017, 27 : 1809 - 1814
  • [5] Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure
    Mutanen, Annika
    Pakarinen, Mikko P.
    CLINICAL NUTRITION, 2017, 36 (05) : 1349 - 1354
  • [6] Postprandial GLP-2 Levels Are Increased After Biliopancreatic Diversion in Diabetic Individuals with Class I Obesity: a Prospective Study
    Cazzo, Everton
    Pareja, Jose Carlos
    Geloneze, Bruno
    Chaim, Elinton Adami
    Lazzarini Barreto, Maria Rita
    Magro, Danila Oliveira
    OBESITY SURGERY, 2017, 27 (07) : 1809 - 1814
  • [7] Basal GLP-1 Levels in Morbidly Obese Patients following Biliopancreatic Diversion Surgery
    de Luis, Daniel
    Pacheco, D.
    Conde, Rosa
    Primo, David
    Aller, Rocio
    Izaola, Olatz
    ANNALS OF NUTRITION AND METABOLISM, 2012, 61 (01) : 70 - 73
  • [8] Activation of Prostaglandin E Receptor 4 Triggers Secretion of Gut Hormone Peptides GLP-1, GLP-2, and PYY
    Coskun, Tamer
    O'Farrell, Libbey S.
    Syed, Samreen K.
    Briere, Daniel A.
    Beavers, Lisa S.
    DuBois, Susan L.
    Michael, Mervyn D.
    Franciskovich, Jeffry B.
    Barrett, David G.
    Efanov, Alexander M.
    ENDOCRINOLOGY, 2013, 154 (01) : 45 - 53
  • [9] GLP-2 levels in infants with intestinal dysfunction
    Sigalet, DL
    Martin, G
    Meddings, J
    Hartman, B
    Holst, JJ
    PEDIATRIC RESEARCH, 2004, 56 (03) : 371 - 376
  • [10] GLP-2 Levels in Infants With Intestinal Dysfunction
    David L Sigalet
    Gary Martin
    Jon Meddings
    Bolette Hartman
    Jens J Holst
    Pediatric Research, 2004, 56 : 371 - 376